Executive Vice President, Finance and Administration (7) · AbbVie Inc. (ABBV)

William Chase

A named executive officer of AbbVie in every fiscal year CompBrief holds from FY2016 to FY2018. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2018

$8,724,786

Salary $1,038,773Stock awards $4,134,594

FY2017: $12,044,593

4th of 6 named executive officers at AbbVie by FY2018 total.

6 named officers on file for AbbVie, FY2018

William Chase’s pay file — $29

  • 3 fiscal years of pay, line by line
  • 3 equity grants, each cited to its filing
  • ABBV’s disclosed peer group of 9 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how AbbVie’s whole pay program stands against its peers

  • AbbVie’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ABBV→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed March 22, 2019 (DEF 14A).

Free

Get William Chase’s full pay file as a PDF — free

More than this page: up to 10 years of William’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

William Chase compensation by year

AbbVie Summary Compensation Table · all 3 fiscal years held
In US dollars, as AbbVie reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2016FY2017FY2018
Salary$979,369$1,008,526$1,038,773
Bonus$0$0$0
Stock awards$3,483,919$3,681,906$4,134,594
Option awards$882,450$980,980$991,720
Non-equity incentive$1,626,000$1,954,549$1,954,549
Pension and deferred compensation$1,697,232$4,223,300$309,063
All other$162,406$195,332$296,087
Total$8,831,376$12,044,593$8,724,786

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: AbbVie Inc. DEF 14A filed March 22, 2019, accession 0001047469-19-001544, and prior-year filings. Open the filing on EDGAR.

How this page was built: the AbbVie Inc. filed document, accession 0001047469-19-001544. Every figure is read from that document and cited to the page and table it appears in. Filed March 22, 2019.

$8.8M
$12.0M
$8.7M
FY16
FY17
FY18
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2018 year-end
TypeUnvested unitsValue at year-endExercise price
PSU54,621$5,035,510—
PSU33,920$3,127,085—
PSU28,350$2,613,587—
Option66,733—$61.36
Option45,840—$114.36
Option31,800—$54.86

Per the Outstanding Equity Awards at Fiscal Year-End table in AbbVie Inc.'s FY2018 proxy; value at the fiscal year-end close, as the company printed it.

AbbVie’s named executive officers, FY2018

as the company reported each
Named executive officerRoleFY2018 total
Richard GonzalezChairman of the Board and Chief Executive Officer$21,271,869
Laura SchumacherVice Chairman, External Affairs and Chief Legal Officer$11,383,159
Carlos AlbanVice Chairman, Chief Commercial Officer$8,983,079
William Chase · this pageExecutive Vice President, Finance and Administration (7)$8,724,786
Michael SeverinoVice Chairman and President$8,607,359
Robert MichaelSenior Vice President, Chief Financial Officer (7)$3,118,888

The full AbbVie compensation record

free company brief

This page is one person within AbbVie's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the AbbVie proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are AbbVie's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

William Chase's compensation dossier · One-time report. No refunds.